4. 5 med tilføjelse af sætningen: "hundens hjerte- karfunktion bør omhyggeligt vurderes før påbegyndelse af behandlingen med Enurace 50 og bør jævnligt overvåges under behandlingen".
With regard to the related to cardiovascular diseases, the SPC is to be modified under section 4.5 to include the sentence “ the dog’ s cardiovascular functionality should be carefully assessed before the start of the treatment with Enurace 50 and it should be periodically monitored during the treatment”.